FDA Investigator Suyang Qin
Suyang Qin has conducted inspections on 108 sites in 9 countries as of 21 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
108
Last Inspection Date:
21 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Poland,
China,
Germany,
Canada,
France,
Switzerland,
Netherlands,
Mexico
FDA Investigators that have inspected at least one site in common with Suyang Qin:
Adaliz Santaliz Cruz,
Amy S Graf,
Andrace L Deyampert,
Andrea D Swingle,
Andrew H Paeng,
Anthony R Petriella,
Barbara D Bennett,
Barbara J Rincon,
Bei Y He,
Benjamin J Dastoli,
Benjamin J Smith,
Bleta Vuniqi,
Brian J Mundo,
Brian M Campbell,
Brian M Marosan,
Brian P Putz,
Brittany M Lowe,
Bryan J Love,
Byungja E Marciante,
Calvin K Cook,
Camerson E Moore,
CDR Sean T Creighton,
Charles I Ann,
Charles L Zhou,
Charles M Spyr,
Christi L Bellmore,
Christina L Bigham,
Christopher S Genther,
Constantin Y Philopoulos,
Corrine M Carter,
Cynthia L Aycock,
Cynthia Li,
Danny Tuntevski,
David A Paterson,
David J Gasparovich,
Debara R Reese,
Debara Reese,
Dellarese L Herbert,
Denise L Burosh,
Dennis E Guilfoyle, PhD,
Dennis R Downer,
Dennis R Hock,
Dina A Tallman,
Dolores Harper,
Donald C Obenhuber, PhD,
Donald W Myrick,
Donna Ltartaglino Besone,
Emest F Bizjak,
Emily J Orban,
Eric S Pittman,
Erin M Miller,
Erma Zaimova,
Felicia E Armbrustmacher,
Francis J Eng,
Gary Durbiel Goldner,
George G Calafactor,
James A Lane,
James D Hildreth,
James R Montero,
Jdouglas Park,
Jean Blackston Hill,
Jeffrey A Sincek,
Jeffrey A Sommers,
Jeffrey D Meng,
Jennifer A Kemp,
Joseph A Piechocki,
Joseph R Strelnik,
Juliane C Lessard,
Karen L Kosar,
Karen M Montgomery (KMM),
Kathryn G Brown,
Kelley L Clark,
Kennita Riddick,
Kim M Downing,
Kimberley A Ricketts,
Kinh Q Mac,
Kristina Mezin,
L'oreal F Walker,
Larry K Austin,
Laura A Grumenfelder,
Laureen F Kononen,
Laureen M Geniusz,
Lauren Iacono Connors, PhD,
LCDR Anastasia M Piliafas Brown,
Leigh Anne Myers,
Li Li,
Linda S Jozefiak,
Lisa M Bellows,
Logan M Ebeling,
Luella J Rossi,
Marc S Neubauer,
Margaret N Persich,
Marlon K Turner,
Martha Sullivan Myrick,
Martin R Vowell,
Matthew J Gretkierewicz,
Meisha R Sampson,
Meisha Waters,
Melina Lrodriguez Upton,
Mercy Oyugi,
Miaja Umaedi,
Michael Shanks, MS,
Michael W Burd,
Michael Y Philopoulos,
Michele L Forster, PhD,
Monica J Wilkins,
Montgomery Montgomery, Karen M,
Muna Algharibeh,
Myra K Casey,
Nailing Zhang,
Nancy A Bellamy,
Natasha N Mccants,
Neali H Lucas,
Norman Wong,
Paranthaman Senthamaraikannan,
Patricia A Cochran,
Patricia H Dlugosz,
Patrick B Cummings,
Patsy J Domingo,
Paula P Demichael,
Perry H Gambrell,
Peyton B Greenwood,
Preston M Lee,
Qiao Y Bobo,
Rachel T Evans,
Rafeeq A Habeeb,
Raymond T Oji,
Rebecca E Dombrowski,
Robert D Tollefsen,
Robert G Taylor,
Robert J Ham,
Robert M Barbosa,
Rodney D Combs,
Rohn R Robertson,
Rosanna M Goodrich,
Sandra A Boyd,
Sarah E Rhoades,
Sarah M Napier,
Sargum C Sood,
Sherri N Rohlf, MD,
Stanley B Eugene, BS, BME,
Stephen R Souza,
Susan F Laska, MS,
Susan P Bruederle,
Talmane J Fisher,
Theodore N Sietsema,
Thomas A Peter,
Thomas J Arista,
Thursaml,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Tracey L Siebesma,
Travis S Bradley,
Twana R Chandler,
Vesa Vuniqi,
Wayne E Seifert,
William D Tingley,
William G Nelson,
William R Brubaker,
Yangmin Ning,
Yumi J Hiramine
Suyang Qin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more